MENU
+Compare
ADCT
Stock ticker: NYSE
AS OF
Jul 25 closing price
Price
$3.28
Change
+$0.05 (+1.55%)
Capitalization
368.22M

ADCT ADC Therapeutics SA Forecast, Technical & Fundamental Analysis

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ADCT with price predictions
Jul 25, 2025

ADCT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ADCT turned positive on July 24, 2025. Looking at past instances where ADCT's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on ADCT as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADCT advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where ADCT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ADCT broke above its upper Bollinger Band on July 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.028). P/E Ratio (0.000) is within average values for comparable stocks, (59.593). ADCT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.512). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (4.470) is also within normal values, averaging (278.844).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ADCT is expected to report earnings to rise 78.05% to -39 cents per share on August 12

ADC Therapeutics SA ADCT Stock Earnings Reports
Q2'25
Est.
$-0.39
Q1'25
Beat
by $0.18
Q4'24
Beat
by $0.18
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.08
The last earnings report on May 14 showed earnings per share of -21 cents, beating the estimate of -40 cents. With 343.66K shares outstanding, the current market capitalization sits at 368.22M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VWAGY11.930.36
+3.11%
Volkswagen AG
RSCF0.08N/A
N/A
Reflect Scientific, Inc.
TBLMF18.00N/A
N/A
Tiger Brands Ltd.
EDVGF2.71N/A
N/A
ENDEAVOUR GROUP LTD.
IGPTF15.23N/A
N/A
IG Port Inc.

ADCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with VTYX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+1.55%
VTYX - ADCT
46%
Loosely correlated
-0.62%
QTTB - ADCT
46%
Loosely correlated
-4.33%
CLRB - ADCT
40%
Loosely correlated
-4.86%
RXRX - ADCT
39%
Loosely correlated
+3.67%
RGNX - ADCT
39%
Loosely correlated
-1.86%
More